237 related articles for article (PubMed ID: 16914082)
1. Overview of endogenous and synthetic melanocortin peptides.
Wilson KR; Todorovic A; Proneth B; Haskell-Luevano C
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):3-20. PubMed ID: 16914082
[TBL] [Abstract][Full Text] [Related]
2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
3. Current trends in the structure-activity relationship studies of the endogenous agouti-related protein (AGRP) melanocortin receptor antagonist.
Wilczynski AM; Joseph CG; Haskell-Luevano C
Med Res Rev; 2005 Sep; 25(5):545-56. PubMed ID: 16044415
[TBL] [Abstract][Full Text] [Related]
4. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
Adan RA
Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
7. Molecular determination of agouti-related protein binding to human melanocortin-4 receptor.
Yang Y; Chen M; Lai Y; Gantz I; Yagmurlu A; Georgeson KE; Harmon CM
Mol Pharmacol; 2003 Jul; 64(1):94-103. PubMed ID: 12815165
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology and physiology of the melanocortin system in fish: a review.
Metz JR; Peters JJ; Flik G
Gen Comp Endocrinol; 2006 Sep; 148(2):150-62. PubMed ID: 16620815
[TBL] [Abstract][Full Text] [Related]
9. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
10. [Melanocortin system].
Levitskaia NG; Kamenskiĭ AA
Usp Fiziol Nauk; 2009; 40(1):44-65. PubMed ID: 19326848
[TBL] [Abstract][Full Text] [Related]
11. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
12. Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors.
Jackson PJ; Yu B; Hunrichs B; Thompson DA; Chai B; Gantz I; Millhauser GL
Peptides; 2005 Oct; 26(10):1978-87. PubMed ID: 16009463
[TBL] [Abstract][Full Text] [Related]
13. The melanocortin system in Fugu: determination of POMC/AGRP/MCR gene repertoire and synteny, as well as pharmacology and anatomical distribution of the MCRs.
Klovins J; Haitina T; Fridmanis D; Kilianova Z; Kapa I; Fredriksson R; Gallo-Payet N; Schiöth HB
Mol Biol Evol; 2004 Mar; 21(3):563-79. PubMed ID: 14694081
[TBL] [Abstract][Full Text] [Related]
14. The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies.
Joseph CG; Wilson KR; Wood MS; Sorenson NB; Phan DV; Xiang Z; Witek RM; Haskell-Luevano C
J Med Chem; 2008 Mar; 51(5):1423-31. PubMed ID: 18271518
[TBL] [Abstract][Full Text] [Related]
15. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
[TBL] [Abstract][Full Text] [Related]
16. A role for syndecan-3 in the melanocortin regulation of energy balance.
Reizes O; Clegg DJ; Strader AD; Benoit SC
Peptides; 2006 Feb; 27(2):274-80. PubMed ID: 16289473
[TBL] [Abstract][Full Text] [Related]
17. Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist.
Rouzaud F; Annereau JP; Valencia JC; Costin GE; Hearing VJ
FASEB J; 2003 Nov; 17(14):2154-6. PubMed ID: 14500544
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.
Wilczynski A; Wang XS; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Richards NG; Edison AS; Haskell-Luevano C
J Med Chem; 2004 Nov; 47(23):5662-73. PubMed ID: 15509165
[TBL] [Abstract][Full Text] [Related]
19. Melanocortins and their receptors and antagonists.
Voisey J; Carroll L; van Daal A
Curr Drug Targets; 2003 Oct; 4(7):586-97. PubMed ID: 14535656
[TBL] [Abstract][Full Text] [Related]
20. Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.
Joseph CG; Wang XS; Scott JW; Bauzo RM; Xiang Z; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Dec; 47(27):6702-10. PubMed ID: 15615519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
